Cargando…
Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors
SIMPLE SUMMARY: As we are facing an increasing incidence of pancreatic neuroendocrine tumors (pNETs), it appears necessary to better classify this disease—and in 2017 the WHO classification introduced a new category of well differentiated grade 3 tumors. pNETs treatment requires some specific backgr...
Autores principales: | Marchese, Ugo, Gaillard, Martin, Pellat, Anna, Tzedakis, Stylianos, Abou Ali, Einas, Dohan, Anthony, Barat, Maxime, Soyer, Philippe, Fuks, David, Coriat, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773540/ https://www.ncbi.nlm.nih.gov/pubmed/35053593 http://dx.doi.org/10.3390/cancers14020433 |
Ejemplares similares
-
Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy
por: Mortier, Victor, et al.
Publicado: (2022) -
Parenchymal Sparing Resection: Options in Duodenal and Pancreatic Surgery
por: Marchese, Ugo, et al.
Publicado: (2021) -
Utility of CT to Differentiate Pancreatic Parenchymal Metastasis from Pancreatic Ductal Adenocarcinoma
por: Barat, Maxime, et al.
Publicado: (2021) -
Multiple Laparoscopic Liver Resection for Colorectal Liver Metastases
por: Nassar, Alexandra, et al.
Publicado: (2023) -
Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions
por: Pellat, Anna, et al.
Publicado: (2021)